STAT

Font of despair: In the fierce competition for science funding, even a typeface glitch can be fatal

A doctor's "fatal error" was not medical but typographical: His funding request for a PTSD project on veterans didn't get past the VA's ruler-wielding enforcers of fonts and type size.

When he first saw the email, just after finishing rounds in the surgical intensive care unit, Dr. Joseph Schlesinger began to panic. A government staffer was writing to inform him that he’d made “a fatal error.”

Standing at the nurses’ pod, surrounded by patients in various states of post-surgical woe, he wondered what he should do next. Life-sustaining machines whirred around him, residents discussed prognoses — but he heard nothing. “It was like I was in a vacuum,” said Schlesinger, an assistant professor of anesthesiology and critical care medicine at Vanderbilt University and a staff physician at the Veterans Affairs medical center in Nashville. None of the cases in front of him needed his immediate attention, and so he left to address the crisis in his inbox.

His “fatal error” was not medical

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks